The body is exposed to foreign pathogens every day, but remarkably, most pathogens are effectively cleared by the innate immune system without the need to invoke the adaptive immune response. Key cellular components of the innate immune system include macrophages and neutrophils and the recruitment and function of these cells are tightly regulated by chemokines and cytokines in the tissue space. Innate immune responses are also known to regulate development of adaptive immune responses often via the secretion of various cytokines. In addition to these protein regulators, numerous lipid mediators can also influence innate and adaptive immune functions. In this review, we cover one particular lipid regulator, prostaglandin E 2 (PGE 2 ) and describe its synthesis and signaling and what is known about the ability of this lipid to regulate immunity and host defense against viral, fungal and bacterial pathogens.
Introduction
While it is common to think of proteins such as cytokines, growth factors and chemokines as being the principle soluble mediators of host defense against pathogens, a variety of unique lipids can also play important roles in regulating innate and adaptive immune function. Lipid signaling molecules derived from arachidonic acid can have both pro-inflammatory and resolving functions (e.g. through the production of leukotrienes, prostaglandins and resolvins) whereas lipids derived from eicosapentaenoic acid are generally considered inhibitory (Dennis & Norris, 2015; Serhan, Chiang, Dalli, & Levy, 2014; WiktorowskaOwczarek, Berezinska, & Nowak, 2015) . In this review, we will focus on the synthesis, signaling and impact of one lipid mediator derived from arachidonic acid metabolism known as prostaglandin E 2 (PGE 2 ).
PGE 2 synthesis
PGE 2 belongs to the family of eicosanoids which are lipid hormonelike signaling molecules that have important roles in inflammatory and physiological functions (Dennis & Norris, 2015) . Homeostatic levels of eicosanoids are always present in mammalian tissue and dysregulation of these levels can have different physiological outcomes (Dennis & Norris, 2015; Wang & Dubois, 2010) . All eicosanoid molecules are produced from the enzymatic modification of arachidonic acid (AA), a polyunsaturated fatty acid esterified in membrane phospholipids of mammalian cells (Black & Rhodes, 2016) . Its metabolism is mediated by a cascade of events starting by being released from cellular membranes by phospholipase A 2 (PLA 2 ) enzymes (Dennis & Norris, 2015; Wang & Dubois, 2010) . Three PLA 2 enzymes can mediate this process, cytosolic calcium-dependent PLA 2 (cPLA 2 ), cytosolic calcium-independent (iPLA 2 ), and secreted PLA 2 (sPLA 2 ) (Agard, Asakrah, & Morici, 2013) . The iPLA 2 enzyme is in charge of maintaining homeostatic levels of free AA, whereas cPLA 2 and sPLA 2 are activated by various stimuli (e.g. microbial recognition) (Dennis & Norris, 2015; Funk, 2001; Suram et al., 2013; Xing, Post, Ostrom, Samardzija, & Insel, 1999 ). Membrane liberated AA can then be further modified to produce prostaglandins or leukotrienes (Wang & Dubois, 2010 ) (see Fig. 1 ). For prostaglandin synthesis, free AA is oxidized by one of the cyclooxygenase (COX) enzymes, COX-1 or COX-2. (Funk, 2001 ) The COX enzymes are structurally equivalent and are around 60% homologous at https://doi.org/10. 1016/j.pharmthera.2017.12.008 the amino acid level (Sugimoto & Narumiya, 2007 ). Yet, while COX-1 is constitutively expressed in most mammalian cells producing homeostatic levels of prostaglandins, COX-2 is inducibly expressed by different stimuli and its expression is highly restricted (Crofford, 1997) . The enzymatic action of COX on AA is twofold; first it oxidizes AA to form prostaglandin G 2 (PGG 2 ), secondly COX reduces PGG 2 to form prostaglandin H 2 (PGH 2 ). Dependent on specific enzymes, PGH 2 can be modified to produce 5 different prostaglandins known as prostaglandin D 2 , prostaglandin I 2 , thromboxane A 2 , prostaglandin F 2α , and PGE 2 (Dennis & Norris, 2015; Regan, 2003; Ricciotti & FitzGerald, 2011) . Alternatively, if AA is metabolized via the actions of 5-lipoxygenase and 5-lipoxygenase activating protein, ultimately leukotriene synthesis can occur (Reid et al., 1990) . In terms of innate immunity there is an intricate "yin and yang" in regulation of innate immune cell function via the actions of prostaglandins versus leukotrienes with prostaglandins generally inhibiting the functions of macrophages and neutrophils whereas leukotrienes can promote function of these cells (Ballinger, McMillan, & Moore, 2007) . Here we will focus on the principal metabolic product of COX-2 activation in myeloid cells, PGE 2 . PGE 2 synthesis is mediated by 3 different enzymes termed: cytosolic PGE synthase (cPGES), microsomal PGE synthase-1 (mPGES-1), and microsomal PGES-2 (mPGES-2). It is known that physiological levels of PGE 2 are maintained by the enzymatic action of cPGES and mPGES-2, whereas mPGES-1 is activated by a wide array of stimuli including pathogen recognition. Upon intracellular production, PGE 2 is secreted to the extracellular compartment by the multidrug resistance protein 4 channel (Russel, Koenderink, & Masereeuw, 2008) . Extracellularly, PGE 2 can signal through 4 different G-protein coupled receptors (GPCRs) or it can be rapidly degraded by 15-hydroxyprostaglandin dehydrogenase to an inactive metabolite termed 15-keto prostaglandin E 2 (O'Callaghan & Houston, 2015) (Fig. 2) . Interestingly, dysregulation of PGE 2 has been implicated to play a role in many disease outcomes, including diabetes and cancer (Gerrard et al., 1980; O'Callaghan & Houston, 2015; Schambelan et al., 1985; Wang & Dubois, 2010) . The full spectrum of its role as an inflammatory mediator is still unknown as both pro-and anti-inflammatory roles have been shown. For example, PGE 2 can mediate endothelial permeability to promote inflammatory cell recruitment (Omori, Kida, Hori, Ozaki, & Murata, 2014 ); yet actions on inflammatory cells themselves are often inhibitory as described below. In this review we will describe the known roles of PGE 2 signaling in host defense against bacterial, viral and fungal pathogens as well as its role in regulating active antimicrobial immunity. We will start by defining the signaling pathway mediated by the PGE 2 receptors which are known as E type prostanoid or EP receptors.
PGE 2 signaling
PGE 2 effector functions have been shown to modulate many biological processes including cell proliferation, apoptosis, angiogenesis, inflammation, and immune surveillance. This is due to the ability of PGE 2 to signal in both autocrine and paracrine manners through four different types of EP GPCRs, namely EP1, EP2, EP3, and EP4 (Dennis & Norris, 2015; O'Callaghan & Houston, 2015; Regan, 2003; Rogers et al., 2014; Sugimoto & Narumiya, 2007) . EP receptors differ in their intracellular signaling pathways, affinity to PGE 2 , as well as tissue and cellular localization. EP signal transduction pathways have been an important topic of study in host defense against microbial pathogens (Agard et al., 2013; Sander, O'Neill, & Pohl, 2017) .
In humans and rats, the EP1 receptor has the lowest affinity for PGE 2 among all EP receptors (Dey, Lejeune, & Chadee, 2006) , whereas in mice, it is the second lowest affinity. It is coupled to a Gq alpha subunit (Gαq), which activates the phospholipase C pathway leading to an increase in intracellular Ca 2 + levels by activation of Ca 2 + protein channels and subsequently activation of protein kinase C (PKC) (Watabe et al., 1993) . Signal transduction mediated by PKC leads to the activation of mitogen-activated protein kinases (MAPK) which are essential in inducing an immune response against viral infections (Huang & Tan, 2012; Liu, Shepherd, & Nelin, 2007) . PKC also leads to the activation of the transcription factors NFAT and NFκB. Dysfunction of the EP1 receptor results in decreased colon tumorigenesis in models of chemically-induced colon cancer in mice, suggesting an important role of this receptor and PGE 2 in inflammation-induced cancer (O'Callaghan & Houston, 2015) . EP1 has not been shown to play major roles in innate immunity, but it can be an important facilitator of naïve T cell differentiation, particularly to suboptimal stimuli (Nagamachi et al., 2007; Sakata, Yao, & Narumiya, 2010) . The EP2 and EP4 receptors mediate most of the immunomodulatory effects of PGE 2 in innate and adaptive immune cells. EP2 and EP4 are coupled to the Gs alpha subunit (Gαs) and activation of these receptors leads to increased cyclic adenosine monophosphate (cAMP) mediated by adenylate cyclase activation (Regan, 2003) . EP4 has a higher affinity for PGE 2 compared to EP2. However, EP2 can increase cAMP levels to a higher degree than EP4 stimulation; which is believed to be caused by a faster desensitization of the EP4 receptor (Regan, 2003) . Increased intracellular cAMP leads to activation of protein kinase A (PKA) and its sister molecule, the exchange protein directly activated by cAMP (EPAC), which activates the transcription factor CREB (Cheng, Ji, Tsalkova, & Mei, 2008) . In addition to CREB activation, EP2 and EP4 signaling can lead to inhibition of glycogen synthase kinase-3 (GSK-3) which inhibits the translocation of β-catenin into the nucleus. Interestingly, inhibition of GSK-3 by EP2 is dependent on increased levels of cAMP, whereas EP4-mediated inhibition of GSK-3 is independent of cAMP and dependent on activation of phosphatidylinositol 3-kinase (PI3K) (Regan, 2003) . The ability of EP4 to directly activate PI3K upon PGE 2 binding also leads to the activation of the extracellular signalregulated kinases (ERKs) that activate early growth response factor-1 which can control the expression of many genes including tumor necrosis factor (TNF)-α, COX-2, and mPGES1 (Regan, 2003) . EP2 and EP4 signaling have also been shown to increase the levels of interleukin-10 (IL-10) while decreasing the levels of TNF-α (Akaogi et al., 2004; Shinomiya et al., 2001) . The fact that EP2 and EP4 can both activate cAMP, but that they also differ in downstream signaling likely explains why these receptors have been shown to have both similar and divergent roles depending on the infection as discussed in greater detail below.
EP3 is the only EP receptor that exists in multiple variants (α, β, and γ) that are generated by alternative splicing of the carboxyl terminal tail (Sugimoto et al., 1992; Sugimoto & Narumiya, 2007) . These variants of the EP3 receptor have equal affinity for PGE 2 , yet they differ in their signal transduction, desensitization, and relative expression. The three isoforms of EP3 can inhibit the activation of cAMP when coupled to the Gi protein subunit, which can also increase the levels of intracellular Ca 2 + and can result in the antagonism of PGE 2 signaling via EP2 and/ or EP4. Alternatively, EP3 can also bind to Gαs and G12/13, meaning that in some instances EP3 signaling can mimic EP2 or EP4 elevations of cAMP (Kim, Dozier, Kerry, & Duffy, 2013; Moreno, 2017) . Fig. 2 summarizes the downstream signaling associated with each of the EP receptors.
Innate Immune Effectors
The first line of innate immune cells that come in contact with potential pathogens are macrophages and neutrophils. Macrophages can differentiate from monocytes in circulation upon extravasation to tissues, but it is now appreciated that most tissue resident macrophages derive from embryonically-seeded tissue-resident stem cells (Ginhoux & Jung, 2014; Gordon, Pluddemann, & Martinez Estrada, 2014 polarize into various effector cells with functions in inflammation, regulation and tissue repair (Liu, Zou, Chai, & Yao, 2014) . As the sentinel cells likely to come in contact with an invading pathogen, macrophages have several important roles. First, they ingest the pathogen and attempt to kill the invader intracellularly. Second, they secrete chemokines to initiate the recruitment of additional immune cells. Third, macrophages can play important roles in processing and presentation of pathogen peptides to initiate the adaptive immune response and they also help clear debris from ongoing immune responses. Finally, macrophages can play important regulatory roles in orchestrating inflammation. In this regard, it is interesting to note that PGE 2 stimulation of macrophages is known to promote an anti-inflammatory phenotype (Fleming et al., 2015) . A second innate immune cell type, neutrophils, derive from the bone marrow and are rapidly recruited to sites of injury or infection armed with pre-formed mediators to fight pathogens (Liu, Yang, Chen, Wang, & Chu, 2013) . The following sections will detail what is known about PGE 2 signaling in the regulation of inflammatory and host-defense processes involving macrophages and neutrophils.
PGE 2 and inflammasome-dependent IL-1β secretion
One of the most critical cytokines needed to initiate inflammation and innate immune responses is interleukin 1 (IL-1)β which is proteolytically cleaved and activated from an immature precursor protein by caspase-1 as part of a multi-protein complex known as an inflammasome. Inflammasomes react to pathogenic stimuli leading to the activation and secretion of both IL-1β and IL-18. If not properly regulated, overzealous inflammasome activation can lead to a form of caspase-1-dependent cell death known as, pyroptosis (Guo, Callaway, & Ting, 2015) . The mechanism of IL-1β secretion by inflammasome activation is known to be dependent primarily on two main signals. Signal 1 is mediated by activation of pattern-recognition receptors (PRRs) [e.g. toll like receptors (TLRs) and nod-like receptors (NLRs)] by pathogen-associated molecular patterns or PAMPs [e.g. lipopolysaccharide (LPS) found in Gram negative bacteria and lipoteichoic acid found in Gram positive bacteria)]. PAMP activation of the PRRs increases the levels of mRNA and ultimately protein for the intracellular immature IL-1β and IL-18 precursors. Signal two is delivered by the recognition of multiple agonists (e.g. adenosine triphosphate or bacterial Type III secretion system proteins) leading to inflammasome aggregation and caspase-1-dependent processing of IL-1β and IL-18 into their mature form (Munoz-Planillo et al., 2013) . The activation of the inflammasome needs to be highly regulated as low activation might lead to a decrease in pathogen clearance and a high activation can lead to the development of IL-1β-driven auto-inflammatory syndromes (Guo et al., 2015) . Dysregulation of one of the members of the inflammasome family, the NLRP3 inflammasome, has been linked to the development of cryopyrin-associated periodic syndrome, as well as to vascular diseases, non-alcoholic fatty liver diseases, obesity and type II diabetes (Mortimer, Moreau, MacDonald, & Chadee, 2016; Strowig, HenaoMejia, Elinav, & Flavell, 2012) .
The role of PGE 2 on inflammasome and IL-1β activity stills needs to be fully elucidated as reports are conflicting. Two groups have reported that elevation of intracellular cAMP inhibits the NLRP3 inflammasome, with subsequent decreased IL-1β secretion (Mortimer et al., 2016; Sokolowska et al., 2015) . Inhibition of the NLRP3 inflammasome by PGE 2 was demonstrated to be dependent on EP2/4-mediated activation of PKA which was found to phosphorylate the Ser295 residue in NLRP3 inhibiting its function (Mortimer et al., 2016) . Furthermore, this residue is found to be mutated in CAPS patients, explaining the overactivation of the NLRP3 inflammasome in these individuals (Sokolowska et al., 2015) .
In other studies however, it has been shown that EP2/EP4 stimulation leads to an increase in IL-1β transcripts and immature protein, which boost IL-1β secretion upon pathogenic stimuli including infections with Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, as well as LPS and Tityus serrulatus venom treatment (Hua et al., 2015; Martinez-Colon, Taylor, Wilke, Podsiad, & Moore, 2017; Zaslona et al., 2017; Zoccal et al., 2016) . Interestingly, leukotriene B 4 (LTB 4 ), an eicosanoid derived from the modification of AA by 5-lipoxygenase (and a metabolite that is often elevated when COX activity is suppressed) seems to have the opposite effect on IL-1β regulation than does PGE 2 (Zoccal et al., 2016) . Administration of LTB 4 was shown to reduce the levels of IL-1β and improve survival in a mouse model of T. serrulatus venom-induce mortality (Zoccal et al., 2016) . In addition, inhibition of COX1/2 by administration of indomethacin, a COX non-selective inhibitor, reduces IL-1β levels in a mouse model of P.aeruginosa-induced acute lung injury (Martinez-Colon et al., 2017) . Moreover, a recent study demonstrated that TLR4-dependent induction of immature IL-1β is dependent on endogenous levels of PGE 2 as indomethacin treatment decreases expression of IL-1β, post-LPS stimulation (Zaslona et al., 2017) .
These discrepancies in the findings of PGE 2 -mediated regulation of IL-1β might be explained by the difference in time of exposure to PGE 2. A short exposure to high levels of PGE 2 inhibits the NLRP3-mediated secretion of IL-1β by a post-translational modification mediated by PKA (Mortimer et al., 2016) . However, longer exposures to PGE 2 boost the levels of intracellular IL-1β by stimulating NFkB and CREB-dependent transcription of the IL-1β gene, thus amplifying amounts of pro-IL-1β for processing after exposure to microbial compounds (Martinez-Colon et al., 2017; Zoccal et al., 2016) . Taking these findings together, manipulation of PGE 2 signaling may be a potential target to control IL-1β-mediated auto-inflammatory syndromes and/or tissue injury, especially in conditions known to be associated with prolonged PGE 2 elevations (e.g. following stem cell transplantation) (Ballinger et al., 2006; Cayeux, Beverly, Schulz, & Dorken, 1993) .
PGE 2 and Neutrophil Extracellular Traps (NETs) formation
Neutrophils are the most abundant leukocyte circulating in the blood and are the first recruited cells to the site of infection after tissue sentinel cells encounter pathogens (Lehrer, Ganz, Selsted, Babior, & Curnutte, 1988; Nauseef & Borregaard, 2014; Wang, 2004) . Upon pathogen recognition, neutrophils can kill microbes by phagocytosis, degranulation (secretion of antimicrobial molecules), and the release of NETs (Papayannopoulos, 2009) . NETs are web-like structures of decondensed chromatin containing the antimicrobial peptides neutrophil elastase (NE) and myeloperoxidase (MPO), which can trap and kill pathogens (Brinkmann et al., 2004) . This recently described antimicrobial pathway has been shown to play a role in the clearance of pathogens that are too big to be engulfed by phagocytosis including Candida albicans hyphae and extracellular aggregates of Mycobacterium bovis (Branzk et al., 2014 ). Yet, they can also play a role in killing of smaller bacterial pathogens including S. aureus, Salmonella typhimurium, and Shigella flexneri (Brinkmann et al., 2004) . NETs release has been shown to be dependent on the scavenger receptor dectin-1, superoxide generation and the intracellular pathway known as autophagy which allows for cellular homeostasis under periods of stress (Remijsen et al., 2011) . Inhibition of either autophagy or NADPH oxidase as well as dectin-1 deficiency can inhibit the formation of NETs (Branzk et al., 2014; Remijsen et al., 2011) . Interestingly, PGE 2 -mediated activation of PKA/EPAC was reported to downregulate NET release (DomingoGonzalez et al., 2016; Shishikura et al., 2016) . This is of high importance in hematopoietic stem cell transplanted (HSCT) patients who have been reported to harbor high levels of PGE 2 in the serum and bronchoalveolar lavage fluid Cayeux et al., 1993; Coomes, Hubbard, & Moore, 2011; Domingo-Gonzalez et al., 2016; . Neutrophils from these patients are unable to induce NET release upon phorbol myristate acetate stimulation or bacterial encounter (Domingo-Gonzalez et al., 2016). Moreover, inhibiting PGE 2 signaling with indomethacin or PKA/EPAC antagonists restores the NET release in neutrophils from HSCT patients (Domingo-Gonzalez et al., 2016) . The main mechanism of PGE 2 -mediated downregulation of NET release has not been elucidated; however, it has been suggested that it might be mediated by inhibition of an alternative pathway such as autophagy rather than a direct inhibition of NET-related molecules (Domingo-Gonzalez et al., 2016) .
PGE 2 and autophagy
Macroauthophagy (herein known as autophagy) is an intracellular homeostatic process for energy conservation in which the cell engulfs cytoplasmic proteins and organelles for degradation (Deretic, Saitoh, & Akira, 2013) . It is characterized by formation of a double membrane vesicle termed an "autophagosome" which fuses with the lysosome to create the "autolysosome", where engulfed material will be destroyed by lysosomal hydrolases (Deretic et al., 2013; Shibutani, Saitoh, Nowag, Munz, & Yoshimori, 2015) . Interestingly, autophagy has been shown to play a pivotal role in the destruction of invading microorganisms, control of inflammation, as well as an essential role in antigen presentation (Deretic et al., 2013) . Autophagy can be induced in different ways including amino acid starvation, mammalian target of rapamycin (mTOR) inhibition, inflammatory cytokines stimulation, as well as PRR (e.g. TLR4) activation (Pilli et al., 2012; Sanjuan et al., 2007; Shi & Kehrl, 2010; Singh, Davis, Taylor, & Deretic, 2006; Tattoli et al., 2012) . Alveolar macrophages are sentinel cells within the lung, and have been shown to primarily clear the bacterial pathogen P. aeruginosa using autophagy machinery (Yuan et al., 2012) . Interestingly, PGE 2 stimulation of alveolar macrophages was able to interrupt the autophagymediated killing of P. aeruginosa (Martinez-Colon et al., 2017) . The direct pathway of how PGE 2 inhibits autophagy-mediated bacterial clearance was not determined, but the EP4-mediated activation of ERK1/2 signaling might explain autophagy inhibition as ERK1/2 is a well-known activator of mTOR, a negative regulator of autophagy (Choi, Jo, Lee, & Choi, 2014) . Additionally, PGE 2 stimulation in macrophages has been shown to downregulate the lipidation of microtubule-associated protein 1A/1B-light chain 3 (LC3), an autophagyrelated protein, and these results were considered a direct measurement of autophagy inhibition (Martinez-Colon et al., 2017) . However, a role for LC3 in non-canonical autophagy processes has recently been reported including a role in the newly identify pathway, LC3-mediated phagocytosis (Heckmann, Boada-Romero, Cunha, Magne, & Green, 2017; Martinez et al., 2015) . Thus, PGE 2 may also limit this process. In contrast to the findings in myeloid cells, PGE 2 has been suggested to induce autophagy-mediated death and LC3 lipidation in fibroblasts (Chen, Chen, Cheng, & Jiang, 2015) . Thus the effect of PGE 2 in autophagy regulation is likely cell and receptor dependent.
PGE 2 and TLR Crosstalk
The recognition of microbial infection is often initiated via interaction of PAMPs with TLRs (Kawai & Akira, 2011) . The TLRs are type I membrane-spanning proteins found either on the cell surface or in endosomes that have leucine-rich ectodomains that interact with the PAMPs. Once activated by ligand, the cytosolic toll-IL-1 receptor or TIR domains activate downstream signaling pathways to initiate responses to infection. Each TLR recognizes distinct PAMPs derived from viruses, bacteria, fungi and parasites (Kawai & Akira, 2011) . Upon activation, adapter proteins such as MyD88 and TRIF can be recruited to initiate the signaling events that ultimately lead to secretion of proinflammatory mediators, antimicrobial effectors and chemokines to stimulate the recruitment of additional leukocytes to fight infection. As such, TLRs play a major role in the orchestration of the innate immune response to infection. As might be predicted, rampant stimulation of TLRs could lead to pathogenic responses and tissue injury; thus, feedback mechanisms exist to dampen TLR activation after initial stimulation, and one important acute feedback mechanism is production of PGE 2 . However chronic production of PGE 2 can hamper long term host defense.
A number of infectious stimuli have been shown to induce COX-2 expression and stimulate synthesis of PGE 2 in various cell types including Candida albicans stimulation of epithelial cells (Deva, Shankaranarayanan, Ciccoli, & Nigam, 2003; Wang, Wang, Chen, Wang, and Liu, 2017) , Leishmania donovani infection in macrophages (Bhattacharjee et al., 2016) , Gram positive lipoteichoic acid (Ahn et al., 2014) , Mycobacterium tuberculosis (Nishimura, Zhao, Gan, Koyasu, & Remold, 2013) in macrophages and numerous viral infections [reviewed in (Sander et al., 2017) ] just to name a few. In macrophages, lipoteichoic acid or the protozoan L. donovani has been shown to induce COX-2 and PGE 2 production via TLR2 stimulation (Ahn et al., 2014; Bhattacharjee et al., 2016) . Stimulation of TLR7/8 by the synthetic agonist R-848 induces phosphorylation of cPLA2α and increases COX-2 expression in neutrophils (Hattermann et al., 2007) and stimulation of TLR4 via Gram negative Eschericia coli induces COX-2 and PGE 2 synthesis in vascular smooth muscle cells (Jimenez et al., 2005) . Thus, a wide range of PAMPs can trigger PGE 2 production via stimulation of many TLRs in various cell types.
Focusing on macrophages which are often the initial innate immune cell to encounter a pathogen, signaling via PGE 2 can have differential effects, some of which activate macrophage function and some of which inhibit it. For example, PGE 2 can stimulate the expression of CD14 which is a LPS co-receptor for TLR4 activation (Iwahashi, Takeshita, & Hanazawa, 2000) . PGE 2 pre-treatment can synergistically stimulate LPS-induced IL-1β and IL-6 expression (Iwahashi et al., 2000) and can upregulate IL-1β transcription in response to prolonged activation via EP2 and EP4 stimulation (Martinez-Colon et al., 2017) . PGE 2 signaling via the EP2 receptor on rat alveolar macrophages has also been shown to activate cAMP and PKA pathways to enhance nitric oxide production (Kim et al., 2011) . When examining the PKA signaling in more detail, it was found that the type I and type II isozymes of PKA differ in their cAMP-binding regulatory (R) subunits and can be differentially regulated by association with a family of scaffold proteins called the protein kinase A anchoring proteins (AKAPs) (Jarnaess & Tasken, 2007) . Kim et al. found that when PGE 2 stimulated AKAP10 interactions with PKA -RI isoforms, that nitric oxide production was enhanced to promote bactericidal functions. Alternatively, when PGE 2 stimulated AKAP-8 interactions with PKA-RII, the secretion of TNFα by these same cells was reduced (Kim et al., 2011) . Such compartmentalized responses to cAMP signaling likely explain the fact that EP2 and EP4 stimulation can lead to both activating and inhibitory signaling events.
Most of the data regarding PGE 2 stimulation of macrophages suggests inhibition or dampening of innate immune function, and one mechanism by which this happens is to block TLR signaling. One of the mechanisms by which this occurs is the ability of PGE 2 to inhibit the translation of TLR4 (Degraaf, Zaslona, Bourdonnay, & Peters-Golden, 2014) . In the absence of TLR4 protein, the signaling cascade to generate NFkB and AP-1 to induce transcription of proinflammatory cytokines is impaired. Another mechanism is for PGE 2 to upregulate interleukin1 receptor-associated kinase M (IRAK-M) (Hubbard et al., 2010) . IRAK-M stably binds the MyD88 adaptor complex following TLR engagement and prevents activation of pathways that initiate NF-κB-induced proinflammatory cytokine production (Janssens & Beyaert, 2003; Kobayashi et al., 2002) . Thus, PGE 2 can limit TLR-mediated cytokine activation in 3 ways, 1) via modulation of PKA-AKAP signaling pathways, 2) via inhibition of TLR protein translation and 3) via IRAK-Minduced blockade of TLR signal transduction. The next section details the known impacts of PGE 2 signaling in orchestrating innate and adaptive immune responses.
PGE 2 influences on adaptive immunity
Clearance of intracellular pathogens generally involves recognition of the pathogen by an antigen presenting cell (most commonly a dendritic cell, but macrophages and B cells are also known to do this), processing of pathogen proteins and presentation of pathogen peptides on cell surface major histocompatibility complex (MHC) class I and class II proteins where they can interact with CD4 and CD8 T cells capable of recognizing these pathogen peptide-MHC complexes. Instructive cytokine signals from the dendritic cells can then shape the effector T cell response. CD4 T cells provide cytokine "help" to activate cytotoxic CD8 T cells which in turn help to kill intracellularly-infected host cells. Activated CD4 cells can provide cognate help to B cells which in turn allows development of plasma cells which can secrete pathogenspecific antibodies to help clear viral or bacterial pathogens (Allie & Randall, 2017; Klenerman, 2012; Zuniga, Macal, Lewis, & Harker, 2015) . Additionally, recognition of pathogen PAMPs (especially viral PAMPs) can stimulate production of type I interferon which is a potent stimulus to upregulate anti-viral genes in the host (Asselin-Paturel & Trinchieri, 2005) and induce cellular apoptosis as a strategy to limit viral or other pathogen replication in the host (Barber, 2000) .
When successful, this finely orchestrated adaptive immune response clears intracellular infection, generally through development of strong Th1 cytokine responses and establishes immunologic memory. PGE 2 can influence development of adaptive immunity at many steps. Short, early exposure to PGE 2 can promote dendritic cell migration (Kabashima et al., 2003; Legler, Krause, Scandella, Singer, & Groettrup, 2006) and upregulate co-stimulatory molecule expression (Krause et al., 2009 ) to promote T cell activation. However, if PGE 2 is present throughout dendritic cell maturation, these dendritic cells may be unable to produce IL-12 necessary to drive strong Th1 responses in CD4 helper cells that are often needed to clear intracellular pathogens (Kalinski, Hilkens, Snijders, Snijdewint, & Kapsenberg, 1997) . In fact, PGE 2 can act on naïve T cells to upregulate cytokine receptors necessary to prime Th17 responses (Boniface et al., 2009) . In this manner, the presence of PGE 2 can shift adaptive immune responses away from the protective Th1 responses which can then allow Th2 or Th17 responses to predominate (Li, Edin, Gruzdev, et al., 2013) . This results in impaired anti-viral or anti-intracellular bacterial immunity and may promote tissue remodeling through induction of Th2-associated matricellular proteins like periostin or IL-17-mediated stimulation of extracellular matrix production (Gurczynski & Moore, 2017; O'Dwyer & Moore, 2017) . If present in high enough doses, PGE 2 can limit T cell activation and proliferation (Kalinski, 2012) . Additionally, in models of allergic lung inflammation, PGE 2 may be beneficial as it can inhibit IL-9, IL-10 and IL-17RB receptor expression all of which serve to limit allergic responses (Li, Edin, Bradbury, et al., 2013) . When considering the regulation of immune responses by PGE 2 overall, the actions are largely to inhibit immune responses to bacterial, viral and fungal pathogens; however, as detailed below, there are instances where PGE 2 signaling is beneficial, rather than harmful for host defense.
PGE 2 and bacterial infection
The role of PGE 2 in host defense against bacterial infections has been well described elsewhere (Agard et al., 2013) . Thus, we will restrict our focus here on how PGE 2 regulates infection by some of the organisms on the World Health Organization's (WHO, 2017; http:// www.who.int/medicines/publications/WHO-PPL-Short_Summary_ 25Feb-ET_NM_WHO.pdf) list of the most critical bacterial pathogens impacting human health which includes Mycobacterium tuberculosis, Pseudomonas aeruginosa, Streptococcus pneumoniae, and Staphylococcus aureus. As noted below, the impact of PGE 2 on these infections is not uniform.
Mycobacterium tuberculosis (MTb) is an intracellular bacteria and the causative agent of tuberculosis, which killed 1.8 million infected individuals in 2015 and according to the WHO has surpassed human immunodeficiency virus (HIV) as the leading cause of death due to a single infectious agent. In response to MTb infection, macrophages produce high levels of PGE 2 partially mediated by activation of the TLR2/p38 MAPK signaling pathway and the nuclear receptor PPARγ (Almeida et al., 2014; Nishimura et al., 2013; Venkataprasad, Shiratsuchi, Johnson, & Ellner, 1996) . Despite the fact that PGE 2 is known to inhibit phagocytosis and killing of many bacterial pathogens by macrophages Serezani et al., 2007) , increased production of PGE 2 and signaling through the EP2 receptor is protective against MTb and EP2 −/− mice are more susceptible to infection, compared to wildtype mice (Kaul et al., 2012) . However, these protective effects are more closely aligned with adaptive immune alterations than innate immune signaling which is not surprising given that MTb replicates intracellularly. EP2 signaling was necessary to mount antigen-specific immunity and to downregulate the number of T regulatory cells which can dampen effector T cell responses (Kaul et al., 2012) . PGE 2 inhibition by indomethacin reduces MTb specific TH1 cells upon MTb infection, suggesting that PGE 2 signaling is necessary to generate MTb specific adaptive immunity (Tonby et al., 2016) . In addition, indomethacin treatment has been shown to activate the DP2 receptor in Th2 cells leading to higher levels of IL-2 and IL-5, which could also influence Mtb responses independent of PGE 2 levels (Tanaka, Hirai, Takano, Nakamura, & Nagata, 2004) . Furthermore, genetic polymorphism of EP2 in humans is correlated with susceptibility to MTb infection, as shown by a study of healthy and infected individuals from a large Chinese Han population (Liang et al., 2016) . Infection with a virulent strain of MTb leads to decreased PGE 2 and high lipoxin A 4 leading to successful spread of the pathogen by induction of macrophage necrosis, whereas high levels of PGE 2 leads to control of infection by induction of apoptosis Chen et al., 2008; Divangahi, Desjardins, Nunes-Alves, Remold, & Behar, 2010) . A shift towards necrosis within alveolar macrophages as a result of decreased levels of PGE 2 post-MTb was dependent on the virulence factor, phospholipase C (Assis et al., 2014) . Interestingly, the role of PGE 2 in MTb infections also seems to be dependent on the stage of infection. During acute infection, COX-2 inhibition leads to a successful pathogen colonization of the lung, whereas an inhibition of COX-2 during chronic infection leads to improved clearance of MTb (Agard et al., 2013; Rangel Moreno et al., 2002) . Pseudomonas aeruginosa is an extracellular Gram-negative, multidrug resistant, opportunistic bacterial pathogen that infects immunocompromised individuals including cystic fibrosis patients and HSCT patients Kobayashi, Kobayashi, & Kawai, 2009) . In contrast to the effects of PGE 2 to promote clearance of intracellular MTb, elevated levels of PGE 2 in the lungs of HSCT patients or bone marrow transplant (BMT) mice are known to enhance susceptibility of the host to P. aeruginosa infection . Conditioning of the host by either total body irradiation or chemotherapy can cause elevations of PGE 2 (Cayeux et al., 1993; Hubbard, Ballinger, Wilke, & Moore, 2008) . In the mouse, one mechanism that has been identified is that lung epithelial cells release transforming growth factor beta (TGFβ) in response to total body irradiation. In turn, the TGFβ binds to receptors on alveolar macrophages to upregulate a miRNA known as miR29b which then destabilizes the mRNA for DNA methyltransferase enzymes (DomingoGonzalez et al., 2015) . In the absence of DNA methyltransferases, the COX-2 gene becomes hypo-methylated and overexpressed promoting the production of PGE 2 post-BMT (Domingo-Gonzalez et al., 2015) . In addition to the elevations of PGE 2 by BMT alone, P. aeruginosa infection can cause macrophages to increase PGE 2 secretion by activation of phospholipase A2α (PA2α) (Hurley, Pirzai, Mumy, Gronert, & McCormick, 2011) . PGE 2 signaling via the cAMP-coupled EP2 or EP4 receptors leads to activation of IRAK-M and phosphatase and tensin homolog on chromosome 10 (PTEN) impairing phagocytosis and P. aeruginosa killing, as well as suppressing production of TNF-α and cysteinyl leukotrienes (Hubbard, Wilke, White, & Moore, 2011; Hubbard et al., 2010) . BMT mice are more susceptible to P. aeruginosa infection unless transplantation has been done with stem cells from either IRAK-M −/− and/or PTEN −/− mice, suggesting that inhibition of IRAK-M and PTEN are potential therapeutic targets to improve P. aeruginosa clearance post-BMT. In addition, improved clearance of P. aeruginosa in the lungs of BMT mice has been achieved by indomethacin treatment which blocks COX function and reduces PGE 2 levels post-transplant (MartinezColon et al., 2017) . PGE 2 has also been shown to downregulate the scavenger macrophage receptor MARCO, which is the receptor necessary for recognition of non-opsonized P. aeruginosa . Thus, P. aeruginosa-induced PA2α activation with subsequent secretion of PGE 2 is a mechanism that confers successful colonization with P. aeruginosa in normal hosts. Moreover, in BMT hosts which have elevations of PGE 2 in the lungs constitutively, infection with P. aeruginosa is particularly deadly (Ojielo et al., 2003) . Streptococcus pneumoniae is a Gram-positive facultative anaerobic bacterium that is responsible for the majority of community-acquired pneumonia and is the main bacterial pathogen inducing mortality in influenza-associated secondary infections (Sharma-Chawla et al., 2016) . Upon S. pneumoniae lung infection, alveolar type II cells upregulate COX-2, secreting high levels of PGE 2 that signal mainly through the EP4 receptors on lung macrophages (Szymanski et al., 2012) . Additionally, neutrophils secrete high amounts of PGE 2 and LTB 4 upon exposure to S. pneumoniae's virulence factor, pneumolysin (Cockeran, Steel, Mitchell, Feldman, & Anderson, 2001) . Signaling through EP4 receptors in alveolar macrophages post-S. pneumoniae infection was shown to decrease the levels of S. pneumoniae-induced cytokines such as TNF-α (Gill et al., 2016) . Moreover, PGE 2 has been shown to play a pivotal role in efferocytosis (apoptotic cell removal) by alveolar macrophages. High levels of PGE 2 − mediated by uptake of apoptotic bodies compromise the immune response to S. pneumoniae by decreasing phagocytosis, bacterial killing, and H 2 O 2 production dependent on EP2/EP4 activation of cAMP (Medeiros, Serezani, Lee, & Peters-Golden, 2009; Salina, Souza, & Serezani, 2017) . Mice deficient in EP2 or treated with indomethacin have improved killing and survival post-S. pneumoniae lung infection (Aronoff et al., 2012; Aronoff, Canetti, & PetersGolden, 2004) . Interestingly, EP3-deficient mice also have improved bacterial clearance, phagocytosis and survival post-S. pneumoniae infection (Aronoff et al., 2009) . The reason for EP3 to influence S. pneumoniae killing was linked to higher production of nitric oxide (NO) by the EP3 −/− alveolar macrophages and one possible explanation for this was that the unchecked signaling of PGE 2 via the remaining EP2 and EP4 receptors might explain this phenomenon (Aronoff et al., 2009) . Additionally, since the EP3γ receptor isoform has been shown to also activate adenylate cyclase in overexpression studies (Kim et al., 2013; Moreno, 2017; Tamma et al., 2003) , this may be the reason EP3-deficient mice experience improved survival and bacterial clearance post-S. pneumoniae lung infection, compared to wildtype mice even though their febrile response was blunted (Aronoff et al., 2009) .
In contrast to these studies which suggest PGE 2 limits host defense against S. pneumoniae, one study evaluating genetic ablation of mPGES-1 with subsequent reduction of PGE 2 showed higher bacterial burden, decreased mouse survival, lower expression of NADPH oxidase and lower NO production post-S. pneumoniae infection (Dolan et al., 2016) . It is not immediately clear how to reconcile these differences, but one possibility is that selective targeting of mPGES-1 caused a redistribution of eicosanoid synthesis that is not fully characterized that may have impacted outcomes. Therefore, the role of PGE 2 in host defense against S. pneumoniae is complex, yet the majority of evidence suggests a negative role of PGE 2 on S. pneumoniae clearance.
Staphylococcus aureus is a Gram positive, biofilm-producing bacterium that has acquired antibiotic resistance to multiple drugs making it one of the leaders of nosocomial infections. S. aureus's lipoteichoic acid is a known inducer of COX-2 expression and PGE 2 signaling (Lin et al., 2001; Somayaji, Ritchie, Sahraei, Marriott, & Hudson, 2008; Venza, Visalli, Cucinotta, Teti, & Venza, 2013; Wang, Ren, et al., 2017) . S. aureus-mediated activation of COX-2/PGE 2 pathway in oral epithelial cells facilitates S. aureus's growth and biofilm production improving bacterial attachment to fibronectin (Wang, Ren, et al., 2017) . In addition, the synergistic interaction between the fungal pathogen Candida albicans and S. aureus is mediated by increased PGE 2 caused by C. albicans infections, inducing improved biofilm formation of S. aureus (Krause, Geginat, & Tammer, 2015) . Thus, S. aureus induction of PGE 2 leads to improved growth and survival of the bacteria at the early stages of infection. However, PGE 2 is also a well-known inducer of TH17 immunity, which is necessary to clear S. aureus infections. One study showed that diabetic mice have low levels of PGE 2 leading to low TH17 immunity and high susceptibility to S. aureus infections (Dejani et al., 2016) . Thus, inhibition of PGE 2 at the early stages of infection might improve S. aureus clearance, whereas at the late stages it might be beneficial to stimulate PGE 2 synthesis to increase IL-17 and improve survival in chronic infections.
In addition to the pathogens discussed in this section, virulence factors of enteric pathogens including Salmonella serotypes (S.enterica, S.dublin, and S.typhimirium), Escherichia coli, and Vibrio cholerae are well-known inducers of PGE 2 as a means of establishing infection and limiting host defense (Agard et al., 2013) . A successful infection of Salmonella depends on the induction of COX-2 expression by ERK1/2 activation and inhibition of COX-2 leads to better killing of intracellular Salmonella in infected macrophages (Uchiya & Nikai, 2004) . Furthermore, in a model of sepsis induced by lethal administration of E.coli's LPS, COX-2 −/− mice have shown improved survival compared to wildtype mice (Ejima et al., 2003) . Thus PGE 2 plays an essential regulatory role in bacterial defense to a wide array of pathogens. Overall, PGE 2 seems to promote growth of extracellular bacterial species by limiting host innate immune responses. Similarly, PGE 2 impairs adaptive immune responses needed to clear intracellular MTb.
PGE 2 and viral infection
Similar to the effects during bacterial infection, PGE 2 is also known to impact host defense against viruses (Sander et al., 2017) . As described above, modulations of TLR signaling would be expected to impact recognition of viral pathogens. Furthermore, impairments in autophagy could alter viral antigen processing and presentation needed to stimulate adaptive immunity (Deretic et al., 2013 ). The section above described the ability of PGE 2 to limit phagocytosis and generation of reactive oxygen species in macrophages and one could assume these same defects might extend to impairments in clearance of ingested virions but the situation can be very complicated. For instance, upregulation of PGE 2 has been shown to inhibit type I interferon production and to limit apoptosis, allowing influenza virus to evade host anti-viral immunity (Coulombe et al., 2014; Full & Gack, 2014) . In contrast, lower levels of PGE 2 production in COX-1 −/− mice infected with influenza was detrimental (Carey et al., 2005) . Many viral infections downregulate expression of MHC class I molecules as a mechanism to escape immune recognition by T cells, but this loss of MHC I can trigger recognition of infected cells by NK cells (Jonjic, Babic, Polic, & Krmpotic, 2008) . PGE 2 has also been shown to impact the ability of NK cells to function (Bankhurst, 1982) and this could result in impaired anti-viral clearance. The impacts of PGE 2 on replication of many different viruses has recently been comprehensively reviewed by Sander et al. (2017) and thus will not be reiterated here. Not surprisingly, the impact of PGE 2 depends on the viral infection being studied. PGE 2 can enhance replication of herpes simplex virus, cytomegalovirus, Epstein-Barr virus, rotavirus, vesicular stomatitis virus, and human T-lymphotrophic virus type III, but has conversely been shown to inhibit replication of coxsackie virus, parainfluenza 3 virus, human immunodeficiency virus and hepatitis B (Sander et al., 2017) . As mentioned above, PGE 2 impacts on influenza outcomes are controversial. More recently, PGE 2 has been reported to enhance dengue virus replication (Lin et al., 2017) and induce programmed cell death 1 expression in T cells responding to hepatitis B virus-infected hepatocytes (Sui, Shi, Gao, Yang, & Wang, 2017) . It should also be noted that parainfluenza 3 virus infection induces PGE 2 expression, which in turn makes the viral-infected host more susceptible to secondary bacterial infection (Laegreid et al., 1989) .
PGE 2 and fungal infection
Prostaglandins have also been studied in fungal infections. As opposed to viral and bacterial pathogens, many yeasts can themselves produce prostaglandins, including PGE 2 (Ells, Kock, Albertyn, & Pohl, 2012; Erb-Downward & Huffnagle, 2007; Erb-Downward & Noverr, 2007; Noverr, Toews, & Huffnagle, 2002) . Production of PGE 2 by yeast has been shown to enhance bacterial growth in mixed biofilms; suggesting that such polymicrobial infections are more difficult to clear (Krause et al., 2015) . In addition, Candida albicans is known to stimulate AA metabolism and generation of PGE 2 by synovial fibroblasts (Lee, Lee, Yang, Su, & Salter, 2009) , alveolar macrophages (Castro, Ralston, Morgenthaler, Rohrbach, & Limper, 1994) , peritoneal macrophages (Villamon, Roig, Gil, & Gozalbo, 2005; Yun et al., 2016) and in epithelial cells via stimulation of TLR2 and TLR4 (Deva et al., 2003) . Fungal mannan and β-glucan are also known to induce PGE 2 via stimulation of mannose receptor and dectin-1 respectively on peripheral blood mononuclear cells (Smeekens et al., 2010) . Collectively, PGE 2 signaling stimulates Th2 and Th17 responses to yeast while limiting the protective Th1 responses (Kundu & Noverr, 2011; Smeekens et al., 2010) , although the effects on IL-17 responses are controversial (Valdez et al., 2012) . PGE 2 can limit the ability of macrophages to clear yeast. For example, PGE 2 can inhibit H 2 O 2 and TNFα production by monocytes limiting killing of Paracoccidioides brasiliensis (Bordon et al., 2007) . Additionally, PGE 2 suppresses phagocytosis and assembly of Factin via an EP2 and EP4-dependent pathway that results in activation of PTEN to cause dephosphorylation and activation of the depolymerizing factor cofilin-1 (Serezani et al., 2012) . In these ways, PGE 2 can limit host response to pathogenic yeast. Given the discussion above about the effects of PGE 2 on TLR4, it is not surprising that antagonism of EP2 or EP4 receptors improves host defense against the yeast Cryptococcus neoformans by promoting TLR4-mediated cytokines and enhancing M1 macrophage polarization to kill the yeast (Shen & Liu, 2015) .
In contrast, there are some studies showing a direct negative impact of PGE 2 on yeast biology. For example, stimulation of C. albicans by PGE 2 can inhibit germ tube formation antagonizing yeast to hyphal transformation (Kalo-Klein & Witkin, 1990) and can repress genes involved in iron uptake and alter expression of genes involved in carbon source catabolism (Levitin & Whiteway, 2007) . Contrary to most yeasts which induce host PGE 2 to promote infection, P. bransiliensis has been shown to limit PGE 2 induction as a way of limiting DC activation in response to this fungus (Fernandes et al., 2015) .
Conclusions
In this review, we have tried to highlight the varied and complex roles of the lipid mediator, PGE 2 , in regulating multiple aspects of innate and adaptive immunity. The various actions of PGE 2 are summarized in Fig. 3 . PGE 2 biology is complicated by the fact that many cell types can produce this lipid mediator and many cell types can respond to stimulation of 4 unique EP receptors. PGE 2 plays important homeostatic functions, but when induced in response to pathogen stimulation, PGE 2 has the ability to impact various aspects of both innate and acquired immunity. The majority of studies suggest that PGE 2 overexpression impairs the function of innate phagocytes such as macrophages and neutrophils and limits Th1 immune responses. In this way, PGE 2 signaling tends to lend the host more susceptible to many extracellular bacterial and fungal infections and many viruses. However, there are important and notable examples such as MTb, hepatitis B and HIV in which PGE 2 production can limit the replication of these pathogens to benefit the host. Unfortunately, this means that indiscriminate strategies to block or overexpress PGE 2 are unlikely to be global strategies to improve health. PGE 2 or EP-receptor-based therapies will likely need to be specifically targeted and employed only when the type of infection is well-characterized. When possible, local delivery of COX-inhibitors, EP agonists or antagonists should also be considered to minimize systemic effects. Additional research is especially warranted to better understand the cross-talk between EP2/4 and EP3 signaling and to understand how and why EP2 and EP4 signaling diverge.
